{"transactions":[{"id":1105894,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T19:44:33.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026,  or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":60200,"source":{"system":"sec-edgar","filing":"0000950170-25-088064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000095017025088064/ownership.xml","form_type":"4"}},{"id":1168182,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - right to Buy","published_at":"2025-04-21T08:06:04.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years."}],"balance_after":17600,"derivative":{"exercise_price":0.538,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-25-033480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000121390025033480/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-18"}},{"id":1168997,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - right to Buy","published_at":"2025-04-18T16:01:08.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years."}],"balance_after":17600,"derivative":{"exercise_price":0.538,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-25-033354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000121390025033354/ownership.xml","form_type":"4"}},{"id":1454399,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2024-07-15T18:42:08.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":176000,"derivative":{"exercise_price":0.363,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001213900-24-061452","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000121390024061452/ownership.xml","form_type":"4"}},{"id":1478422,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:14:06.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":36700,"source":{"system":"sec-edgar","filing":"0000950170-24-073662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000095017024073662/ownership.xml","form_type":"4"}},{"id":1690677,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T20:20:00.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":4827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has elected to receive fully vested shares of the Issuer's common stock in lieu of cash retainer fees payable for service on the Issuer's Board of Directors and any committees thereof. The number of shares issued represents the quotient of (A) the amount of such fees divided by (B) the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share."}],"balance_after":20200,"source":{"system":"sec-edgar","filing":"0001209191-24-000603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919124000603/doc4.xml","form_type":"4"}},{"id":1756106,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2023-10-23T16:26:34.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on October 19, 2024, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":41000,"derivative":{"exercise_price":0.32,"expiration_date":"2033-10-19","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001013762-23-005831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000101376223005831/ownership.xml","form_type":"4"}},{"id":1766471,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T18:23:27.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":6985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has elected to receive fully vested shares of the Issuer's common stock in lieu of cash retainer fees payable for service on the Issuer's Board of Directors and any committees thereof. The number of shares issued represents the quotient of (A) the amount of such fees divided by (B) the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share."}],"balance_after":15373,"source":{"system":"sec-edgar","filing":"0001209191-23-051692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919123051692/doc4.xml","form_type":"4"}},{"id":1835050,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T17:25:04.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":3958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has elected to receive fully vested shares of the Issuer's common stock in lieu of cash retainer fees payable for service on the Issuer's Board of Directors and any committees thereof. The number of shares issued represents the quotient of (A) the amount of such fees divided by (B) the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share."}],"balance_after":8388,"source":{"system":"sec-edgar","filing":"0001209191-23-041217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919123041217/doc4.xml","form_type":"4"}},{"id":1853764,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T18:42:30.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-037548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919123037548/doc4.xml","form_type":"4"}},{"id":1892998,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T21:12:13.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has elected to receive fully vested shares of the Issuer's common stock in lieu of cash retainer fees payable for service on the Issuer's Board of Directors and any committees thereof. The number of shares issued represents the quotient of (A) the amount of such fees divided by (B) the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share."}],"balance_after":4430,"source":{"system":"sec-edgar","filing":"0001209191-23-029632","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919123029632/doc4.xml","form_type":"4"}},{"id":2226483,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T19:54:27.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-038177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919122038177/doc4.xml","form_type":"4"}},{"id":2415762,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T17:52:31.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will vest and become exercisable as follows: (i) 8,333 Shares will vest Shares on the first anniversary of the date of grant, (ii) 694 Shares on the last day of the next 23 months commencing with the month next following such first anniversary and (iii) 705 Shares on the last day of the 24th month next following such first anniversary, subject to Mr. Williams continuing to provide services to the Company through the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":19.57,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-006516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725276/000120919122006516/doc4.xml","form_type":"4"}},{"id":2440384,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T22:33:42.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":34804,"source":{"system":"sec-edgar","filing":"0001209191-22-002488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919122002488/doc4.xml","form_type":"4"}},{"id":2549697,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T20:34:15.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":2980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":22496,"source":{"system":"sec-edgar","filing":"0001209191-21-059436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121059436/doc4.xml","form_type":"4"}},{"id":2645481,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T13:56:33.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date."}],"balance_after":14000,"derivative":{"exercise_price":4.55,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-21-044693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044693/doc4.xml","form_type":"4"}},{"id":2645480,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T13:56:33.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":19516,"source":{"system":"sec-edgar","filing":"0001209191-21-044693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044693/doc4.xml","form_type":"4"}},{"id":2758536,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T17:41:05.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":1215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":18102,"source":{"system":"sec-edgar","filing":"0001209191-21-025037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121025037/doc4.xml","form_type":"4"}},{"id":2916335,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T22:01:47.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":16887,"source":{"system":"sec-edgar","filing":"0001209191-21-002169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121002169/doc4.xml","form_type":"4"}},{"id":3016741,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T20:23:18.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":15947,"source":{"system":"sec-edgar","filing":"0001209191-20-053132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120053132/doc4.xml","form_type":"4"}},{"id":3092614,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:47:17.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":1011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":14567,"source":{"system":"sec-edgar","filing":"0001209191-20-040412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120040412/doc4.xml","form_type":"4"}},{"id":3112139,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:49:24.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":7.18,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-036319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120036319/doc4.xml","form_type":"4"}},{"id":3183962,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T20:44:39.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":2717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":13556,"source":{"system":"sec-edgar","filing":"0001209191-20-023204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120023204/doc4.xml","form_type":"4"}},{"id":3228177,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T21:18:21.000Z","date":"2020-03-04","kind":"purchase","acquired":true,"shares":2000,"price":5.78,"value":11560.0,"ownership":{"direct":true},"balance_after":10839,"source":{"system":"sec-edgar","filing":"0001209191-20-016061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120016061/doc4.xml","form_type":"4"}},{"id":3327528,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:46:14.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":1743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":8839,"source":{"system":"sec-edgar","filing":"0001209191-20-000342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120000342/doc4.xml","form_type":"4"}},{"id":3401407,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:09:00.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":2418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":7096,"source":{"system":"sec-edgar","filing":"0001209191-19-051626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119051626/doc4.xml","form_type":"4"}},{"id":3471746,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:51:09.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":4678,"source":{"system":"sec-edgar","filing":"0001209191-19-040363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119040363/doc4.xml","form_type":"4"}},{"id":3488285,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T01:14:23.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2019."}],"balance_after":5000,"derivative":{"exercise_price":7.46,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-037571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119037571/doc4.xml","form_type":"4"}},{"id":3569353,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T20:38:39.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":1364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":3036,"source":{"system":"sec-edgar","filing":"0001209191-19-022543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119022543/doc4.xml","form_type":"4"}},{"id":3709618,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T22:45:17.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":1544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":1672,"source":{"system":"sec-edgar","filing":"0001209191-19-001224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119001224/doc4.xml","form_type":"4"}},{"id":3892775,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:57:04.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2018."}],"balance_after":5000,"derivative":{"exercise_price":24.94,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118038139/doc4.xml","form_type":"4"}},{"id":4117498,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":78316,"kind":"person","name":"Williams Eddie","position":1,"cik":"0001725276","reported_name":"Williams Eddie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-02T23:49:16.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall vest monthly over a period of three years commencing January 2, 2018."}],"balance_after":10000,"derivative":{"exercise_price":14.37,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-000364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118000364/doc4.xml","form_type":"4"}}]}